{"id":18570,"date":"2015-12-07T11:57:26","date_gmt":"2015-12-07T16:57:26","guid":{"rendered":"http:\/\/therapytoronto.ca\/news\/?p=18570"},"modified":"2015-12-07T22:14:28","modified_gmt":"2015-12-08T03:14:28","slug":"statins-may-reduce-the-occurrence-of-strokes-due-to-larger-artery-atherosclerosis","status":"publish","type":"post","link":"https:\/\/therapytoronto.ca\/news\/2015\/12\/statins-may-reduce-the-occurrence-of-strokes-due-to-larger-artery-atherosclerosis\/","title":{"rendered":"Statins may reduce the occurrence of strokes due to larger artery atherosclerosis"},"content":{"rendered":"<p>From the Hiroshima University media release:<\/p>\n<blockquote>\n<p id=\"first\" class=\"lead\"><a href=\"http:\/\/therapytoronto.ca\/news\/wp-content\/uploads\/2013\/01\/vitamins_pills.jpg\"><img loading=\"lazy\" class=\"alignright size-full wp-image-9629\" src=\"http:\/\/therapytoronto.ca\/news\/wp-content\/uploads\/2013\/01\/vitamins_pills.jpg\" alt=\"drugs\" width=\"300\" height=\"199\" \/><\/a>The results of &#8220;The Japan Statin Treatment Against Recurrent Stroke (J-STARS)&#8221; study led to <strong>the hypothesis that statins reduce the occurrence of strokes due to larger artery atherosclerosis<\/strong>.<\/p>\n<div id=\"text\">\n<p>J-STARS <strong>examined whether pravastatin, a traditional statin widely used in the clinic, reduces the recurrence of strokes and respective subtypes<\/strong> in non-cardioembolic stroke patients. The study also examined whether the use of pravastatin favorably impacts the occurrence of other vascular events, and stroke-related functional outcomes were explored.<\/p>\n<p>Statins are widely used to reduce cholesterol levels in blood. <strong>High cholesterol levels are associated with cardiovascular diseases such as strokes, so statins are thought to be beneficial for stroke prevention<\/strong>. However, these findings are obtained from patients without prior stroke, and the preventive effect is less robust in patients with prior stroke.<\/p>\n<p>J-STARS is a multicenter, randomized, open-label, blinded-endpoint, parallel-group study of patients who experienced a non-cardioembolic ischemic stroke. <strong>In total, 1578 patients were recruited and randomly assigned to either the pravastatin group or the control group<\/strong>.<\/p>\n<p>During a follow-up of about 5 years, the incidence of recurrent strokes was about 2.6%\/year in both groups. <strong>The onset of atherothrombotic infarction, a stroke subtype, was clearly less frequent in the pravastatin group, whereas no significant difference was found for other stroke subtypes<\/strong>. No significant difference was found between the two groups in terms of the occurrence of adverse effects, which included cancer and laboratory examinations.<\/p>\n<p>Professor Masayasu Matsumoto, a J-STARS principal investigator at Hiroshima University said &#8220;<strong>the pravastatin dose used in this study is lower than that used in studies from Western countries, but it is the approved standard dose in Japan<\/strong>.&#8221; He explained &#8220;Stroke is a heterogeneous disease with different etiologies with or without underlying arterial pathologies. Thus, the benefits of statin may be different depending on the subtypes of the stroke.&#8221;<\/p>\n<p><strong>The majority of previous studies defined stroke as a whole with no distinction between subtypes<\/strong>. Moreover, current international guidelines uniformly recommend the use of statin for secondary stroke prevention.<\/p>\n<p>According to Professor Matsumoto, &#8220;Further studies are required to determine whether such guidelines are applicable for Asians. <strong>Although the current study has certain limitations, J-STARS can contribute to the establishment of guidelines for using statins to prevent strokes caused by larger artery atherosclerosis<\/strong>.&#8221;<\/p>\n<\/div>\n<\/blockquote>\n<!-- AddThis Advanced Settings generic via filter on the_content --><!-- AddThis Share Buttons generic via filter on the_content -->","protected":false},"excerpt":{"rendered":"<p>From the Hiroshima University media release: The results of &#8220;The Japan Statin Treatment Against Recurrent Stroke (J-STARS)&#8221; study led to the hypothesis that statins reduce the occurrence of strokes due&#8230; <a class=\"read-more-link\" href=\"https:\/\/therapytoronto.ca\/news\/2015\/12\/statins-may-reduce-the-occurrence-of-strokes-due-to-larger-artery-atherosclerosis\/\">Read more &raquo;<\/a><!-- AddThis Advanced Settings generic via filter on get_the_excerpt --><!-- AddThis Share Buttons generic via filter on get_the_excerpt --><\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[321,357,361,358],"tags":[],"_links":{"self":[{"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/posts\/18570"}],"collection":[{"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/comments?post=18570"}],"version-history":[{"count":1,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/posts\/18570\/revisions"}],"predecessor-version":[{"id":18579,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/posts\/18570\/revisions\/18579"}],"wp:attachment":[{"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/media?parent=18570"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/categories?post=18570"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/tags?post=18570"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}